AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OncoSil Medical Ltd

0.001

0.000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:0.001

Open:0.001

Low:0.001

Close:0.001

52wk High:0.002

52wk Low:0.001

Shares:- -

Float Shares:- -

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

OncoSil Medical Ltd

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.oncosil.com.au

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OSLOB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSLOB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSLOB.AU\",,,,,undefined,":{"symbol":"OSLOB.AU","market":"AU","secType":"STK","nameCN":"OncoSil Medical Ltd","latestPrice":0.001,"timestamp":1766120400000,"preClose":0.001,"halted":0,"volume":0,"delay":0,"nameEN":"OncoSil Medical Ltd","floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"12-19 16:00:00 AEDT","open":0.001,"high":0.001,"low":0.001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766358000000},"marketStatusCode":7,"adr":0,"listingDate":1721052000000,"exchange":"ASX","adjPreClose":0.001,"openAndCloseTimeList":[[1766098800000,1766120400000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSLOB.AU\",,,,,undefined,":{"symbol":"OSLOB.AU","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.001,"amplitude":0,"preClose":0.001,"low":0.001,"week52Low":0.001,"pbRate":"--","week52High":0.002,"institutionHeld":0,"latestPrice":0.001,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.001,"prevYearClose":0.002,"prevWeekClose":0.001,"prevMonthClose":0.001,"prevQuarterClose":0.001,"fiveDayClose":0.001,"twentyDayClose":0.001,"sixtyDayClose":0.001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSLOB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSLOB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.oncosil.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.5},{"period":"ytd","weight":-0.5}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0281},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.0935},{"period":"1year","weight":0.2415},{"period":"ytd","weight":0.2485}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.","exchange":"ASX","name":"OncoSil Medical Ltd","nameEN":"OncoSil Medical Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OSLOB.AU\",market:\"AU\",,,undefined,":null}}